Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Does this mean Nader will not be talking about "high triple digits" value of CYDY tomorrow ... ? Or will he?
This short attack (I guess this is one) is to be partly blamed on Nader and the BODs. They perfectly set the stage for the short seller, by ongoing overpromising and non delivering of BLA and at the same time they try to enrich themselves on longterm shareholders.
If Nader would have once delivered 2018 or early 2019 on the funding issue (you know it was never a problem in Naders mind) and if he would not have dropped the ball on the cancer story, we would have probably left OTC already in 2019.
You forgot it is all the fault of the FDA and Pestell.
You know, things just happen ...
Yeah, when he is so sure that BLA will be delivered until end of February (oh boy who believes this crap), why did they gave themselves a timeline of 6 months for BLA delivering for their "performance" incentive? Does not make any sense.
You can' t make this s.it up!
If I got a dollar for every time NP mentioned or promised non dilutive funding in the last 18 months ...
The SP in Germany is not impressed about todays news so far ...
I would guess they try to legitimate as much bonus as possible before we uplist to a serious stock exchange. After uplisting they are not able to blatantly grab into the cookie jar as they did in the past.
Looking back a few months, Nader and the BOD have already a history of questionable self servicing at the costs of the shareholders where the company was in desperate needs of funding. This should be addressed at one point.
I am still feed up with the whole Pestell story. Not alone that Nader and the BOD awarded them lots of bonuses and shares for this mess, it also cost us valuable time in the cancer section, since Nader dropped the ball on the cancer story. It also not in the interest of the shareholders to cut back or limit the development of Leronlimab because of "lack or limited funds" or in other words, the money is needed to compensate management instead of going on full speed with Leronlimab.
I have no problem with compensating management, but it must be at appropriate terms and amounts.
No wonder we do not pass the sniff test of any serious company. One of the first thing they probably do is to look in our books and for what we spend money.
https://www.osc.gov.on.ca/en/Proceedings_rad_20200127_canada-cannabis-corporation.htm
Raymond Kindiak, Commissioner and Chair of the Panel
File No. 2019-34
January 27, 2020
ORDER
WHEREAS the Registrar advised the parties that the February 6, 2020 attendance would not proceed on that date;
ON READING the email responses of the parties;
IT IS ORDERED THAT:
the attendance scheduled for February 6, 2020 is vacated;
the respondents shall serve and file a motion, if any, regarding Staff’s Disclosure or seeking disclosure of additional documents by no later than February 25, 2020; and
a further attendance in this proceeding is scheduled for March 6, 2020 at 10:00 a.m., or on such other date and time as provided by the Office of the Secretary and agreed to by the parties.
I hope there were lots of shorts in yesterdays volume and that the usual suspects went short big time. Btw. I also very much hope we gap up today at >1,5USD! :)
Amen
Naders salary, his salary increases, why we have to pay two CFOs lately, for what reason/ service the two BODs get each 20kUSD/ months, when will this BOD contracts be terminated etc. should definitely also be addressed.
We make lots of micro raises and the fees for Paulson (9-10% for each raise, if he is involved) and the above described expenses make a high portion of this raised money.
I doubt he will answer any question regarding this topics.
The milk cow is already to it knees and those guys try to press the last drop of milk out of the cow.
It would be a good question for today to ask Nader to lay out the parameters for what he calls/ describes as a "good deal".
What are the minimum requirements for a deal he would agree to sign and what are no goes?
Then it would be possible to compare those values to the bandwidth which is common in this sector. I guess Naders expectations for certain parameters will be on the upper limit or above.
An icecream seller where the sharholders dream about 100USD/share and at the same time it is unknown how to pay the electricity bill for the next few months ...
Nader can have the best strategy ever, without proper financing it will be nothing more than a pipe dream.
Are we going to start raising money at <500kUSD tranches soon? (Yes I know, this is because a deal is imminent (soooooooon), lol)
For the Conference call I would like to have short term financing (cash to keep the lights on for at least 6 months) addressed.
For whatever new plan Nader presents at the conference call, he and his new CFO better have a solid short term financing plan and backup plan at hand. For much too long time, financial planning did not get any attention and the consequences of this can be seen in every deep red account of 98% of shareholders.
Please no new faerie tales like "Gates foundation" or "US military" which only could be a source of funding at one point in the future.
(hint: Paulson does also not count as solid financial planning. Also "financing is not a problem" is not a solid form of financial planning)
Without any significant revenues, who will fund this new journey?
We will keep at the OTC for a few more years, Investors will get even more scares and Paulson will not find any investor with a brain to play with him his game.
Will BOD fund those "few" million USD out of their pocket?
Does not make much sense, but lately most action of Nader made any sense either.
There never was and there never will be any accountability for management at CYDY under the helm of Nader and the current BOD. If there would be any accountability or performance related action, the salary raises of Nader and the two BODs (20kUSD/months) would be reversed.
Just remember for what Nader got his last raises and how SP developed since then ...
I am wondering when the inflection point occurs where Naders inabilities and mismanagement finally outpaces the superiority of the science and shareholders start fleeing the ship.
How many Nader promises and stunts do we have to sustain until he resigns or gets kicked out?
BODs have lots of shares and I hope their patience with Naders "performance" is coming to an end soon ...
Any new potential partner will think twice about to make any negotiations with Nader as CEO of CYDY. He negotiates a deal for several months and he pushes until only the signature is missing. Then suddenly he halts and wants to negotiate with other potential partners? What kind of business mentality is this?
Nader is totally unreliable and untrustworthy. No wonder we have not signed any deal.
That Lero is working in the cancer space is known or assumed for quite some time now, so why does he use the cancer story to stop the deal for HIV now?
What has the HIV combo deal to do with the potential of Leronlimab in the cancer space? Would the Leonlimab price for HIV application increase if it would also be effective in the cancer space? Does the price of medicine increase if it has more possible applications?
Anyway I do not understand why we have not signed already any kind of contract with the track record of Lero in the HIV space.
I would really appreciate if management would finally tell the shareholder what the heck they are doing. In September Nader almost exploded because the deal in negotiation was sooooo goood. Now few months later it is not good enough and Nader prefers raising money at 0,30cents?
This is madness.
Yeah it sounds to good to be true. The science is undisputable.
In my mind I am jumping between live changing opportunity because of the science and total distrust when it comes to Nader and the SP over the last 1,5 years. Recognizing the ongoing SP downtrend and the Nader "talk" rectify my tendency to see the glass half empty.
I have averaged "down" to approx 52cents. So I assume if he closes any deal with some significant upfront cash I will be green within some trading hours.
Hope dies last.
So when will the last chapter be written?
Judging by how Nader treated this horse until now, I conclude he will ride this horse to death.
Does it really matter? The date will be blown anyway like the other dates.
You can add my 120k shares.
Thats the problem.
Just because Nader says something like "very interested" does not count as fact in my opinion. It is just talk and knowing Nader for a very long time, talk is cheap.
He is also "very enthusiastic" to close a deal soon for months and you can see what this enthusiasm had lead to.
Talk The Talk, Walk The Walk!
Minimal dilution?
CYDY lacks proper funding/ financing for more than 1,5 years.
Naders failed negotiations (if there were any serious negotiations in the first place) and bad management (never had a plan "B" only plan "P" (Paulson)) cost the longterm shareholders dearly.
I do not want to think about what happens, if FDA pulls an other obstacle into the BLA application. How are we going to survive another few months with those micro raises, which will also dry up soon?
Whats about the test which Nader literally "pulled out of the garbage" last august and which should have generate some revenue until now? Never heard anything again from Nader regarding this topic.
Talk The Talk, Walk The Walk!
Maybe Nader could make some connex to Bitcoin or Cannabis in the company name. I guess this would boost the shareprice immediately.
(just kidding)
I think most of the shareholders have a different opinion what the "best deal for sh" is.
But hey why not give him time until summer or autumn or winter 2020?
Giving him more time after the "financing is around the corner" fubar did indeed play out very well for the shareholders.
Or why do we not hand out free passes for his next missed deadlines in 2019 in advance and for spring 2020 and beyond? Who cares anyways?
What transparency do you mean in terms of finances? "Financing is around the corner" or "there are several financing options/ opportunities" and other pipe dreams (e.g. Chinese parties (if this ever was real)) busts, he went straight to Paulson like a junky to his dealer and killed the long term shareprice with this reckless behavior. He never had financial long term planning or a plan "B". He only had plan "P", which stands for Paulson.
Telling somebody or give somebody very strongly the impression that within 6 weeks some kind of significant deal will happen and after this period expires with (again) no result he simply changes the narrative. Now the story is "data room" and further negotiation and this time no date. He rather had no clue how this deals work in this industry in the first place or he simply tried to gain some time. There is something very wrong in my opinion.
All those hints in this interviews and shareholder conferences over the last 18 months with e.g. Chinese investor, which gave us the impression that our financial problems will or could be solved soon did not materialize. But I guess this is just how it is played at the OTC. Tell them something they can believe in and change the story every 2 months.
It seems, that with some shareholders he can play this game forever and will get a pass each time ...
There were some significant steps forward in the medical field but financials were and are a total disaster.
As far as I remember two BODs still earn 20kUSD/ month for whatever services they provide to CYDY. I think it was approx. in the time period, when Nader got his raises.
Sure 20kUSD/ month is pocketmoney for Welch, but if I remember correctly they received shares instead of cash lately and therefore (could) increase their amount of shares significantly due to the low shareprice. Which is also a nice side effect for them.
So the two BODs and Nader are the only once who have made some money during the last year where as the average shareholder lost double digits at the same time.
At which date is "enough is enough"? Are we going to wait patiently for BLA and some kind of a deal until Q1 2020 or Q2 2020 or until golden quarter 202x?
The shareholders and deadsick patient deserve more trasperancie after all this fails (and lieing) in matter of financing.
The only winners are the BOD and Nader, big time. The losers are shareholders and sick patients which pay the highest price. It is time for a change. How many Nader folks are left?
If BOD has participated, why do we pay 90.000USD to Paulson? This does not make sense.
OSC order
WHEREAS on September 30, 2019, the Ontario Securities Commission held a hearing at 20 Queen Street West, 17th Floor, Toronto, Ontario, with respect to the first attendance in this proceeding;
ON HEARING the submissions of the representativesforStaff of the Commission (Staff) and for each of the respondents;
IT IS ORDERED THAT:
By no later than October 30, 2019, Staff shall disclose to each of the respondents non-privileged relevant documents and things in the possession or control of Staff (Staff’s Disclosure);
By no later than January 23, 2020, the respondents shall serve and file a motion, if any, regarding Staff’s Disclosure or seeking disclosure of additional documents;
By no later than January 23, 2020, Staff shall:
file and serve a witness list on each respondent,
serve a summary of each witness’s anticipated evidence on each respondent, and
indicate any intention to call an expert witness, including providing the expert’s name and the issues on which the expert will give evidence; and
A further attendance in this proceeding is scheduled for February 6, 2020 at 10:00 a.m. or on such other date and time as may be agreed by the parties and set by the Office of the Secretary.
" Raymond Kindiak "
Raymond Kindiak
OSC order
WHEREAS on September 30, 2019, the Ontario Securities Commission held a hearing at 20 Queen Street West, 17th Floor, Toronto, Ontario, with respect to the first attendance in this proceeding;
ON HEARING the submissions of the representativesforStaff of the Commission (Staff) and for each of the respondents;
IT IS ORDERED THAT:
By no later than October 30, 2019, Staff shall disclose to each of the respondents non-privileged relevant documents and things in the possession or control of Staff (Staff’s Disclosure);
By no later than January 23, 2020, the respondents shall serve and file a motion, if any, regarding Staff’s Disclosure or seeking disclosure of additional documents;
By no later than January 23, 2020, Staff shall:
file and serve a witness list on each respondent,
serve a summary of each witness’s anticipated evidence on each respondent, and
indicate any intention to call an expert witness, including providing the expert’s name and the issues on which the expert will give evidence; and
A further attendance in this proceeding is scheduled for February 6, 2020 at 10:00 a.m. or on such other date and time as may be agreed by the parties and set by the Office of the Secretary.
" Raymond Kindiak "
Raymond Kindiak
Regarding bribes I think it would be definitely much cheaper than in the USA. :)